OCTANe Biomedical Innovation Series: Breast Cancer - Innovations in Screening, Diagnosis, and Treatment March 19, 2009

---

Orange County is home to some of the top companies leading the
fight in breast cancer screening, diagnosis and treatment. Come hear about the biomedical
innovations taking place at NeoMatrix, Cianna Medical, Clarient. We will also hear
from an investor at Waveland Capital that has made numerous investments in the
breast cancer treatment space.
Featured Companies:
NeoMatrix- Based in Irvine, NeoMatrix develops innovative devices that allow women and their doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test, is the only fully automated, noninvasive breast disease screening device designed for use in the Primary Care setting as part of an annual well-woman visit.Speaking on behalf of NeoMatrix will be John Stroh, CEO. John has 25 years of experience in the medical technology field including roles at Kadmus Pharmaceuticals, Atairgin Technologies, and Johnson & Johnson. John has also been instrumental in raising over $2 billion for client companies while working in the investment banking industry.
Clarient - Based in Aliso Viejo, Clarient is a
leader in cancer diagnostics, dedicating ourselves to collaborative
relationships with the healthcare community as we translate cancer discovery
and information into better patient care. Were dedicated to providing clarity
to a complex disease by using a number of technologies and approaches to help
our clients diagnose their cancer cases.Speaking on behalf of Clarient will be Dr. Ron Bloom, Chief Medical Officer.Dr. Bloom came to Clarient from Irvine, CA-based US Labs, where he served as Senior Medical Director since 2002. Prior to that, Dr. Bloom spent more than two decades serving in senior academic, consultative and clinical roles with leading hospitals and healthcare enterprises principally in the specialization of cancer care.
Cianna Medical - Based in Aliso Viejo, Cianna Medical is a women's health company dedicated to the innovative treatment of early-stage breast cancer. When diagnosed early, most women have the option to save their breast by choosing breast conservation therapy (BCT). The company manufactures and markets the SAVI breast brachytherapy applicator. Cianna's SAVI technology allows physicians to precisely target radiation to the area that needs it most, minimizing exposure to healthy tissue.Speaking on behalf of Cianna Medical will be Steve Gex, Chairman. Mr. Gex previously served as Chairman of BioLucent, Inc, a women's health company dedicated to the early detection and treatment of breast cancer. BioLucent was acquired in Sept. 2007 by Hologic, Inc. Prior to BioLucent, mr. Gex co-founded and served as CEO of Biopsys Medical. At Biopsys, Mr. Gex guided the company's IPO and subsequent sale to Johnson & Johnson.
Waveland Capital - Waveland has
underwritten private equity investments since its inception in 2000, primarily
in the medical technology industry. We aim to provide sophisticated investors
with well structured and well researched investment opportunities in companies
with rapid growth potential, strong intellectual property, large and growing
markets, and experienced management teams.Speaking on behalf of Waveland Capital will be Michael Greer, Chairman and CEO. Mr. Greer has significant experience as an investment banker, financial advisor, corporate executive and entrepreneur. As Wavelands CEO, he specializes in sourcing and structuring energy and private equity transactions, identifying sources of capital, and advising clients through all stages of corporate growth. Since co-founding Waveland Capital Partners in 2000, he has established the firm as a highly regarded boutique investment bank that has consistently performed for its clients in both good and difficult market conditions. Mr. Greer previously served as Managing Director of Taurus Capital Group, LLC, where he led the firms private equity operations.


Organized by OCTANe
OCTANe is fueling "innovation development" in Orange County and Southern California. By connecting people, capital and technology, OCTANe accelerates entrepreneurs and company development for Orange County's biomedical and information technology community...

---

Ticket Info:  

• OCTANe member, Free
• OCTANe Next member, Free
• Non-member, $25.00

Official Website: http://octanecancerinnovations-upcoming.eventbrite.com